Sign in
4

Changes in Ownership

Roivant Sciences Ltd. Filed Acc 0001140361-24-041788

CEO sold 1,983,257 shares at $11.79 ($23,382,600)

  • CEO disposed of 498,539 shares (other)
  • CEO acquired 1,550,000 shares (option exercise)
  • CEO gave up 10,945 shares (to pay taxes)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Gline Matthew CEO 2024-09-20 Shares withheld for taxes 10b5-1 −10,945 $11.97 $131,012 18,303,800 D
Gline Matthew CEO 2024-09-23 Option exercise 10b5-1 +1,550,000 $3.85 $5,967,500 19,853,800 D
Gline Matthew CEO 2024-09-23 Sale 10b5-1 −1,983,257 $11.79 $23,382,600 17,870,543 D
Gline Matthew CEO 2024-09-23 Other disposition 10b5-1 −498,539 $11.97 $5,967,512 17,372,004 D
Derivatives
Gline Matthew CEO 2024-09-23 Option exercise · Stock Option (Right to Buy) 10b5-1 −1,550,000 14,973,184 D
Open-market sales · 1,983,257 sh · avg $11.79 · $23,382,600
Loading xslF345X05/form4.xml…